Ranked by reported Q1 2025 13F market value
Share of total reported institutional value in LIPO held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Tower Research Capital LLC (TRC) | 3K | $7K | — | 0.060% | 0.00% |
| 2 | MAI Capital Management | 125 | $314 | 0.0% | 0.003% | 0.00% |
| 3 | BANK OF AMERICA CORP /DE/ | 7 | $18 | 0.0% | 0.000% | 0.00% |
| 4 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | — | 0.000% | — |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LIPO — a direct measure of their conviction.
Filings activity in LIPO during Q1 2025, grouped by how each filer changed its position.
2 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2025 | 4 | +0.0% | 1.96% | +1.84 pp | $0M | +1506% |
| Q4 2024 | 4 | — | 0.12% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying LIPO stock.
Based on Q1 2025 13F filings, institutional ownership of Lipella Pharmaceuticals Inc. stands at 2.0%, held across 4 reporting institutions.
Tower Research Capital LLC (TRC) is the largest reported institutional holder of LIPO, with approximately 2,708 shares worth $0.00B as of Q1 2025.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of LIPO.
Our composite Smart Money Score for LIPO is 47 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in LIPO during Q1 2025, while 1 fully exited. 0 added to existing positions and 2 trimmed.
LIPO institutional ownership rose by 1.84 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 100.0% of all reported 13F value in LIPO, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Lipella Pharmaceuticals Inc. (LIPO) Institutional Ownership